Brought to you by 
MediChem, Elitra develop antibacterial drugs
02 Jul 2001
Executive Summary
Elitra Pharmaceuticals (antimicrobial compounds) and MediChem Life Sciences (proteomics and combinatorial chemistry) will team up to jointly discover and develop drug candidates to prevent and treat microbial infections over a three-year period.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MediChem, Elitra develop antibacterial drugs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice